Keeping vulnerable children safe from pertussis: preventing nosocomial pertussis transmission in the neonatal intensive care unit.
OBJECTIVE
To examine the impact of different acellular pertussis booster vaccination strategies on the probability of a nosocomial pertussis outbreak occurring and the distribution of outbreak sizes observed for each intervention strategy.


METHODS
Neonatal intensive care unit.


METHODS
We developed a stochastic, agent-based simulation model to examine the impact of booster vaccination strategies for pertussis on health care-related transmission.


RESULTS
Our results demonstrate that healthcare worker booster vaccination decreases the probability of secondary transmission from 49% (base case, no boosting) to 2% (if 95% of healthcare workers are boosted) and decreases final outbreak size. Boosting family caregivers did not have a clinically significant impact on nosocomial disease transmission.


CONCLUSIONS
The provision of booster vaccine to healthcare workers in the neonatal intensive care unit substantially reduces the risk of hospital-centered pertussis outbreaks in a manner that enhances the health of hospitalized children. A formal health economic analysis of this finding is currently under way. Policies to protect patient safety in pediatric facilities should include compliance with the United States Advisory Committee on Immunization Practices, which recommends provision of pertussis booster vaccination to healthcare workers.
Child Health Evaluative Sciences, Research Institute of the Hospital for Sick Children, Toronto, Ontario, Canada. amy.greer@sickkids.ca
Amy L
AL
Greer
David N
DN
Fisman
D001886:Bordetella pertussis / Q000276:immunology*; D003428:Cross Infection / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission; D004196:Disease Outbreaks / Q000517:prevention & control*; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D006282:Health Personnel; D006801:Humans; D007117:Immunization, Secondary; D007223:Infant; D007231:Infant, Newborn; D017757:Infectious Disease Transmission, Professional-to-Patient / Q000517:prevention & control; D007363:Intensive Care Units, Neonatal / Q000706:statistics & numerical data*; D008954:Models, Biological; D010567:Pertussis Vaccine / Q000008:administration & dosage*; D013269:Stochastic Processes; D022282:Vaccines, Acellular / Q000008:administration & dosage; D014917:Whooping Cough / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control / Q000635:transmission
D010567:Pertussis Vaccine; D022282:Vaccines, Acellular